Presented by: Jolly Mazumdar, PhD, MBA, Chimeron Bio
About Episode 4
In episode 4, Jolly shares an intimate look at the ups and downs of building a company that develops novel RNA delivery platform technologies within oncology, infectious diseases and rare genetic disorders therapeutic areas.
About Jolly Mazumdar
Jolly is CEO of Chimeron Bio. Prior to Chimeron, she served in clinical development leadership roles at GlaxoSmithKline in the divisions of Immuno-oncology and Personalized Oncology. She obtained her PhD in cell biology from the University of Georgia and has an MBA from Columbia Business School.
Complete the form to the right for access to episode 4 of the Charles River Innovator's Series.
